Leukaemia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are 18 years of age or older
- People who have been diagnosed with AML (a type of blood cancer) within the last four weeks
- People who are planned to receive chemotherapy treatment at home
Who may not be able to join:
- People who do not speak or understand Danish
- People who are unable to carry out blood count measurements at home or receive blood transfusions at home
- People who do not reach remission (where the cancer is no longer detectable) after their second round of chemotherapy will not be able to continue in the trial
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Lars Kjeldsen, MD, Rigshospitalet, Denmark
Phone: +4526227757
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Technical Performance of the Hemoscreen Instrument; Self-Administered Blood Measurements at Home; Self-Administered Blood and Platelet Transfusions at Home; Replacement of Scheduled Day Hospital Visits by Home Care and Self-Testing; Vital Signs Before and After Home Transfusions; Extra Healthcare Visits and Hospital Admissions; Transfusion Reactions and Adverse Events; Types of Transfusion Reactions
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.